CN108553690A - A kind of porous fibroin microballoon and preparation method thereof for mixing strontium - Google Patents
A kind of porous fibroin microballoon and preparation method thereof for mixing strontium Download PDFInfo
- Publication number
- CN108553690A CN108553690A CN201810333874.7A CN201810333874A CN108553690A CN 108553690 A CN108553690 A CN 108553690A CN 201810333874 A CN201810333874 A CN 201810333874A CN 108553690 A CN108553690 A CN 108553690A
- Authority
- CN
- China
- Prior art keywords
- strontium
- porous
- fibroin
- petroleum ether
- silk fibroin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种掺锶的多孔丝素微球的制备方法,属于生物医用材料技术领域。The invention relates to a method for preparing porous silk fibroin microspheres doped with strontium, which belongs to the technical field of biomedical materials.
背景技术Background technique
骨、软骨组织对人体起着非常重要的支持、保护等作用,传统的骨修复方法是利用自体骨和异体骨进行骨移植治疗,这样的方法不仅受限于供骨资源,且价格昂贵,同时使用异体骨还容易产生免疫排斥等不良反应。随着组织工程和再生医学的发展,其在骨再生方面已取得了巨大成功,再生的骨具有正常的功能和生物活性。在骨修复过程中,需要构建负载细胞及生长因子的三维支架,如多孔海绵支架、纤维网格支架和水凝胶等,相比于这些支架形式,微载体具有可直接注射于组织缺陷部位而免除外科手术过程的优点,同时作为细胞载体,它可以扩大细胞的三维培养、提高细胞培养面积并维持细胞表型。其中多孔微载体表面具有开孔,内部具有贯通孔结构,可方便细胞进入到微载体内部,避免细胞在培养过程中造成损伤。此外,多孔微载体还可以加强细胞营养物质和代谢产物运输,为细胞生长提供更多比表面积,能极大地提高细胞接种数量。Bone and cartilage tissue play a very important role in supporting and protecting the human body. The traditional bone repair method is to use autologous bone and allogeneic bone for bone transplantation. This method is not only limited by bone supply resources, but also expensive. The use of allogeneic bone is also prone to adverse reactions such as immune rejection. With the development of tissue engineering and regenerative medicine, it has achieved great success in bone regeneration, and the regenerated bone has normal functions and biological activities. In the process of bone repair, it is necessary to construct three-dimensional scaffolds loaded with cells and growth factors, such as porous sponge scaffolds, fiber mesh scaffolds, and hydrogels. Compared with these scaffold forms, microcarriers have the ability to be directly injected into tissue defects and With the advantage of exempting from surgical procedures, and as a cell carrier, it can expand the three-dimensional culture of cells, increase the cell culture area and maintain cell phenotype. The surface of the porous microcarrier has openings, and the interior has a through-hole structure, which can facilitate cells to enter the interior of the microcarrier and avoid damage to the cells during the culture process. In addition, porous microcarriers can also enhance the transport of cell nutrients and metabolites, provide more specific surface area for cell growth, and greatly increase the number of cell seeding.
丝素蛋白是由18种人体氨基酸组成的一种天然大分子蛋白,在体内能被分解重新降解成单体氨基酸,降解产物无毒,且能被吸收。相比于常用的合成材料如聚乳酸等,丝素蛋白可以模拟组织中蛋白质组分和功能,且具有良好的生物相容性、降解性和易加工修饰、低免疫原性等优点,更易于满足生物材料的要求。锶是骨骼组成的重要微量元素,具有促进成骨和抑制破骨的作用。锶还可以促进多功能干细胞向成骨细胞分化,能提高骨矿物质密度,增强骨硬度、骨诱导能力及骨传导性,最终改善骨微细结构和骨质量,促进新骨再生与修复。Silk fibroin is a natural macromolecular protein composed of 18 kinds of human amino acids. It can be decomposed and re-degraded into monomer amino acids in the body. The degradation products are non-toxic and can be absorbed. Compared with commonly used synthetic materials such as polylactic acid, etc., silk fibroin can mimic the protein components and functions in tissues, and has the advantages of good biocompatibility, degradability, easy processing and modification, and low immunogenicity. meet the requirements of biological materials. Strontium is an important trace element in bone composition, which can promote osteogenesis and inhibit osteoclastosis. Strontium can also promote the differentiation of pluripotent stem cells into osteoblasts, increase bone mineral density, enhance bone hardness, osteoinductive ability and osteoconductivity, ultimately improve bone microstructure and bone quality, and promote new bone regeneration and repair.
发明内容Contents of the invention
本发明针对现有微载体在组织工程应用中存在的制备材料性能不稳定和结构形貌研究不够完善等主要问题,结合丝素蛋白优势特点,提供了一种以丝素蛋白和氯化锶为主要材料,采用乳液法结合冷冻干燥技术制备的掺锶丝素蛋白基多孔微球。本发明制备的掺锶丝素多孔微球主要用于骨的修复,可有效避免细胞流失、骨量不足等问题,增强对关节骨的支撑。本发明的具体技术方案如下:The present invention aims at the main problems of existing micro-carriers in the application of tissue engineering, such as the unstable properties of the prepared materials and the incompleteness of the research on the structure and morphology, and combines the advantages and characteristics of silk fibroin to provide a kind of microcarrier based on silk fibroin and strontium chloride. The main material is strontium-doped silk fibroin-based porous microspheres prepared by emulsion method combined with freeze-drying technology. The strontium-doped silk fibroin porous microspheres prepared by the invention are mainly used for bone repair, can effectively avoid problems such as cell loss and insufficient bone mass, and enhance support for articular bones. Concrete technical scheme of the present invention is as follows:
本发明公开了一种掺锶的丝素多孔微球,多孔微球的组成成分是丝素和氯化锶,所述的多孔微球的孔隙率在80%以上,孔径为5-40μm,氯化锶重量比占总重量的5%-38%。The invention discloses a strontium-doped silk fibroin porous microsphere. The composition of the porous microsphere is silk fibroin and strontium chloride. The weight ratio of strontium chloride accounts for 5%-38% of the total weight.
本发明是一种制备掺锶多孔丝素微球的方法,所采用的具体制备步骤如下:The invention is a method for preparing strontium-doped porous silk fibroin microspheres, and the specific preparation steps adopted are as follows:
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into silk fibroin solution;
2)取石油醚于烧杯中,在-30℃—-50℃预冷3.5h以上;在这个温度范围和时间内才能做出来,温度太低太高形貌都会变化,时间太短冷冻效果不好,也无法成型。2) Take petroleum ether in a beaker and pre-cool it at -30°C—-50°C for more than 3.5 hours; it can only be made in this temperature range and time, the shape will change if the temperature is too low or too high, and the freezing effect is not good if the time is too short Well, it can't be molded either.
3)再另取石油醚于新烧杯中,加入乳化剂,使两者混合均匀;3) Take another petroleum ether in a new beaker, add an emulsifier, and mix the two evenly;
4)将2%-6.5%(w/v)丝素蛋白溶液、0.1%-4%(w/v)氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;掺锶的好处在于:目前研究主要是在丝素蛋白材料中添加BMP-2等与干细胞体外向成骨细胞分化和成骨,及VEGF等与成血管有关细胞因子提高治疗效果。然而,细胞因子在临床应用中仍面临:半衰期短,释放浓度不易控制,主要从动物身上获得,代价高,易变质,常伴有免疫排斥反应等重要问题。因此,寻找新的促血管化和促进成体干细胞向成骨分化的组织工程来源因子,是采用组织工程技术修复骨缺损的研究热点;4) Mix 2%-6.5% (w/v) silk fibroin solution and 0.1%-4% (w/v) strontium chloride evenly, add the solution in 3), and stir into a uniform spherical shape; the benefits of strontium doping Because: the current research is mainly to add BMP-2 etc. to the silk fibroin material and stem cells to differentiate into osteoblasts and osteoblasts in vitro, and VEGF and other cytokines related to angiogenesis to improve the therapeutic effect. However, cytokines still face in clinical application: short half-life, difficult to control the release concentration, mainly obtained from animals, high cost, easy to deteriorate, often accompanied by important problems such as immune rejection. Therefore, finding new tissue engineering-derived factors that promote vascularization and osteogenic differentiation of adult stem cells is a research hotspot in repairing bone defects with tissue engineering technology;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于冷冻环境静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it in a frozen environment to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
作为进一步地改进,本发明所述的步骤6)中的掺锶多孔丝素蛋白微球通过后续醇类处理增强其力学性能。未经过醇类处理的丝素会溶于水中,同时此步有利于洗去残留的乳化剂。As a further improvement, the mechanical properties of the strontium-doped porous silk fibroin microspheres in step 6) of the present invention are enhanced by subsequent alcohol treatment. Silk fibroin that has not been treated with alcohol will dissolve in water, and this step is beneficial to wash away the residual emulsifier.
作为进一步地改进,本发明所述的掺锶多孔丝素蛋白微球根据生物矿化原理获得具有锶离子稳定缓释能力的碳酸锶矿化的丝素蛋白多孔微球。经过矿化,锶离子可以达到缓释效果,未经过矿化放入水中,锶离子会很快释放完,无法达到预期效果。As a further improvement, the strontium-doped porous silk fibroin microspheres of the present invention obtain strontium carbonate mineralized porous silk fibroin microspheres with the ability of stable and slow release of strontium ions according to the principle of biomineralization. After mineralization, strontium ions can achieve a sustained release effect, but if put into water without mineralization, strontium ions will be released quickly, and the expected effect cannot be achieved.
与现有技术相比,本发明具有以下突出特点:Compared with the prior art, the present invention has the following prominent features:
1)优良的生物相容性:丝素蛋白作为一种天然蛋白分子,已普遍用于保健食品行业,不会对人体产生刺激作用;1) Excellent biocompatibility: As a natural protein molecule, silk fibroin has been widely used in the health food industry and will not stimulate the human body;
2)可注射性:丝素蛋白微球相比于水凝胶、多孔海绵支架等,可以直接注射于组织缺陷部位,可克服特殊部位、复杂结构等引起的骨缺损不易操作等问题;2) Injectability: Compared with hydrogels and porous sponge scaffolds, silk fibroin microspheres can be directly injected into tissue defects, which can overcome the problems of difficult operation of bone defects caused by special parts and complex structures;
3)促进骨骼修复:锶是人体不可缺少的一种微量元素,具有成骨诱导等能力,可提高骨修复的效果;同时丝素蛋白作为细胞载体的主要材料,可模拟细胞外基质的蛋白成分;3) Promote bone repair: strontium is an indispensable trace element in the human body, which has the ability to induce osteogenesis and can improve the effect of bone repair; at the same time, silk fibroin, as the main material of cell carriers, can simulate the protein components of extracellular matrix ;
4)通过本发明制备得到的掺锶丝素多孔微球,可以进行锶的缓释,有效地克服了从动物身上获取生长因子使用存在等多种问题;4) The strontium-doped silk fibroin porous microspheres prepared by the present invention can perform sustained release of strontium, effectively overcoming various problems such as obtaining growth factors from animals and using them;
5)成本低廉,环保无污染。5) Low cost, environmental protection and no pollution.
具体实施方式Detailed ways
下面通过具体实施例对本发明的技术方案作进一步的详细说明,以下实施例是对本发明的解释而本发明并不局限于以下实施例。The technical solution of the present invention will be further described in detail through specific examples below. The following examples are explanations of the present invention and the present invention is not limited to the following examples.
实施例1Example 1
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.01g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.01g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
所得的多孔微球的组成成分是丝素和氯化锶,所述的多孔微球的孔隙率在80%以上,孔径为5μm—40μm,氯化锶重量比占总重量的5%-38%。The composition of the obtained porous microsphere is silk fibroin and strontium chloride, the porosity of the porous microsphere is above 80%, the pore diameter is 5 μm-40 μm, and the weight ratio of strontium chloride is 5%-38% of the total weight .
实施例2Example 2
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成4%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 4% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.01g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.01g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
实施例3Example 3
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成6.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 6.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.01g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.01g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
实施例4Example 4
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.01g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.01g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
实施例5Example 5
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.05g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.05g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
实施例6Example 6
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.2g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.2g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
实施例7Example 7
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.4g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.4g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
实施例8Example 8
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-30℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -30°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.2g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.2g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
以下表格提供了对比例1-2与实施例2作对比,对比例1-2仅仅改变了丝素浓度这一技术特征,其余技术特征均与实施例2相同,从而通过形貌观察得出了丝素浓度的选择对于本发明技术方案的重要性。The following table provides a comparison between Comparative Example 1-2 and Example 2. Comparative Example 1-2 only changed the technical feature of silk fibroin concentration, and the rest of the technical features are the same as in Example 2. The selection of silk fibroin concentration is important for the technical solution of the present invention.
以下表格提供了对比例3与实施例4、7作对比,对比例3仅仅改变了氯化锶含量,其余技术特征均与实施例4相同,从而通过形貌观察得出了氯化锶含量选择对于本发明技术方案的重要性。The following table provides a comparison between Comparative Example 3 and Examples 4 and 7. Comparative Example 3 only changed the content of strontium chloride, and the rest of the technical features are the same as in Example 4, so that the selection of the content of strontium chloride can be obtained by observing the morphology. For the importance of the technical solution of the present invention.
以下表格提供了对比例4-5与实施例5作对比,对比例3仅仅改变了预冷温度这一技术特征,其余技术特征均与实施例5相同,从而通过形貌观察得出了预冷温度选择对于本发明技术方案的重要性。The following table provides comparison between Comparative Examples 4-5 and Example 5. Comparative Example 3 only changed the technical feature of pre-cooling temperature, and the rest of the technical features are the same as in Example 5, thus obtaining the pre-cooling temperature by morphology observation. The importance of temperature selection for the technical solution of the present invention.
实施例9Example 9
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.05g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.05g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
7)将6)获得的多孔丝素微球与NH4HCO3混合放置2d后,用乙醇固定30min后,用去离子水冲洗干净乙醇和NH4HCO3,再经过冷冻干燥获得具有锶离子稳定缓释能力的碳酸锶矿化的丝素蛋白多孔微球。7) Mix the porous silk fibroin microspheres obtained in 6) with NH 4 HCO 3 and place them for 2 days, fix them with ethanol for 30 minutes, rinse the ethanol and NH 4 HCO 3 with deionized water, and freeze-dry to obtain strontium ion-stabilized Strontium carbonate mineralized silk fibroin porous microspheres with sustained release capability.
实施例10Example 10
1)将蚕茧剪碎、脱胶、溶解后,再经过过滤、透析、浓缩成2.5%(w/v)的丝素蛋白溶液;1) Shred silkworm cocoons, degumming and dissolving them, then filter, dialyze and concentrate them into 2.5% (w/v) silk fibroin solution;
2)取450ml石油醚于500ml烧杯中,在-50℃预冷4h;2) Take 450ml of petroleum ether in a 500ml beaker and pre-cool at -50°C for 4h;
3)再取40ml石油醚于100ml新烧杯中,加入0.7ml span-80,使两者混合均匀;3) Take 40ml of petroleum ether in a new 100ml beaker, add 0.7ml of span-80, and mix the two evenly;
4)将10ml的丝素蛋白溶液、0.05g氯化锶混合均匀,加入3)中的溶液,搅拌成均匀球形;4) Mix 10ml of silk fibroin solution and 0.05g of strontium chloride evenly, add the solution in 3), and stir to form a uniform spherical shape;
5)将4)溶液迅速倒入2)中预冷的石油醚中,再置于-50℃静置沉淀;5) Pour the solution of 4) into the pre-cooled petroleum ether in 2) quickly, and then place it at -50°C to stand for precipitation;
6)在冷冻氛围下除去5)溶液中的石油醚,获得含冰晶的掺锶丝素蛋白微球,将该丝素蛋白微球进行冷冻,再通过冷冻干燥可获得干燥的掺锶的多孔丝素蛋白微球。6) Remove the petroleum ether in the solution of 5) in a freezing atmosphere to obtain strontium-doped silk fibroin microspheres containing ice crystals, freeze the silk fibroin microspheres, and then obtain dry strontium-doped porous silk by freeze-drying protein microspheres.
7)将6)获得的多孔丝素微球与乙醇混合固定30min后,用去离子水冲洗干净乙醇,再经过冷冻干燥获得不溶于水的掺锶的丝素蛋白多孔微球。7) The porous silk fibroin microspheres obtained in 6) were mixed and fixed with ethanol for 30 min, the ethanol was rinsed with deionized water, and then freeze-dried to obtain water-insoluble porous silk fibroin microspheres doped with strontium.
最后,还需要注意的是,以上列举的仅是本发明的几个具体实施例子以及对比例子。显然,本发明不限于以上实施例子,还可以有许多变形。本领域的普通技术人员能从本发明公开的内容直接导出或联想到的所有变形,均应认为是本发明的保护范围。Finally, it should be noted that the above examples are only a few specific implementation examples and comparative examples of the present invention. Apparently, the present invention is not limited to the above examples, and many variations are possible. All deformations that can be directly derived or associated by those skilled in the art from the content disclosed in the present invention should be considered as the protection scope of the present invention.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810333874.7A CN108553690B (en) | 2018-04-13 | 2018-04-13 | Strontium-doped porous silk fibroin microspheres and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810333874.7A CN108553690B (en) | 2018-04-13 | 2018-04-13 | Strontium-doped porous silk fibroin microspheres and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108553690A true CN108553690A (en) | 2018-09-21 |
| CN108553690B CN108553690B (en) | 2020-08-07 |
Family
ID=63535040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810333874.7A Active CN108553690B (en) | 2018-04-13 | 2018-04-13 | Strontium-doped porous silk fibroin microspheres and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108553690B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117122736A (en) * | 2023-08-28 | 2023-11-28 | 北京大学口腔医学院 | An apoptotic vesicle self-assembly modified PLGA porous microsphere composite material and its use |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1505495A (en) * | 2001-02-23 | 2004-06-16 | 史密夫和内修有限公司 | Method for producing bone graft substitute |
| CN1560115A (en) * | 2004-03-10 | 2005-01-05 | 复旦大学 | Silk protein nano-microspheres and preparation method thereof |
| CN101244277A (en) * | 2008-02-14 | 2008-08-20 | 苏州大学 | Silk fibroin drug-loaded microspheres and preparation method thereof |
| CN103041447A (en) * | 2012-12-14 | 2013-04-17 | 深圳先进技术研究院 | Injectable silk fibroin bone repair filling sustained-release material, and preparation method and application thereof |
| CN103333350A (en) * | 2013-06-09 | 2013-10-02 | 浙江大学 | Preparation method of sericin microspheres |
| CN104602713A (en) * | 2012-04-13 | 2015-05-06 | 塔夫茨大学信托人 | Methods and compositions for preparing a silk microsphere |
| CN106620861A (en) * | 2016-12-09 | 2017-05-10 | 宁波芸生纺织品科技有限公司 | Silk fibroin/strontium carbonate composite material and preparation method thereof |
| CN106729982A (en) * | 2016-12-29 | 2017-05-31 | 浙江大学 | A kind of preparation method of silk fibroin nanosphere |
| CN106834204A (en) * | 2017-01-16 | 2017-06-13 | 西北民族大学 | A kind of cell culture SFL microcarriers and its preparation method and application |
-
2018
- 2018-04-13 CN CN201810333874.7A patent/CN108553690B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1505495A (en) * | 2001-02-23 | 2004-06-16 | 史密夫和内修有限公司 | Method for producing bone graft substitute |
| CN1560115A (en) * | 2004-03-10 | 2005-01-05 | 复旦大学 | Silk protein nano-microspheres and preparation method thereof |
| CN101244277A (en) * | 2008-02-14 | 2008-08-20 | 苏州大学 | Silk fibroin drug-loaded microspheres and preparation method thereof |
| CN104602713A (en) * | 2012-04-13 | 2015-05-06 | 塔夫茨大学信托人 | Methods and compositions for preparing a silk microsphere |
| CN103041447A (en) * | 2012-12-14 | 2013-04-17 | 深圳先进技术研究院 | Injectable silk fibroin bone repair filling sustained-release material, and preparation method and application thereof |
| CN103333350A (en) * | 2013-06-09 | 2013-10-02 | 浙江大学 | Preparation method of sericin microspheres |
| CN106620861A (en) * | 2016-12-09 | 2017-05-10 | 宁波芸生纺织品科技有限公司 | Silk fibroin/strontium carbonate composite material and preparation method thereof |
| CN106729982A (en) * | 2016-12-29 | 2017-05-31 | 浙江大学 | A kind of preparation method of silk fibroin nanosphere |
| CN106834204A (en) * | 2017-01-16 | 2017-06-13 | 西北民族大学 | A kind of cell culture SFL microcarriers and its preparation method and application |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117122736A (en) * | 2023-08-28 | 2023-11-28 | 北京大学口腔医学院 | An apoptotic vesicle self-assembly modified PLGA porous microsphere composite material and its use |
| CN117122736B (en) * | 2023-08-28 | 2024-04-05 | 北京大学口腔医学院 | Apoptosis vesicle self-assembled modified PLGA porous microsphere composite material and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108553690B (en) | 2020-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103877617B (en) | Two cross-linked hydrogel of injectable fibroin protein-alginate and preparation method thereof and using method | |
| Chen et al. | 3D printing electrospinning fiber-reinforced decellularized extracellular matrix for cartilage regeneration | |
| US20220054704A1 (en) | Concentrated aqueous silk fibroin solution and use thereof | |
| US9925301B2 (en) | Methods of producing and using silk microfibers | |
| CA2863967C (en) | Liquefaction of bone matrix | |
| CN114887116B (en) | 3D printing bone defect repairing support loaded with mesenchymal stem cell extracellular matrix and preparation method thereof | |
| CN109999227A (en) | A kind of preparation method and application based on fibroin albumen and the embedded hydrogel cartilage biomimetic scaffolds of the blended nanofiber of chitin | |
| CN102218160A (en) | Preparation and application of nerve tissue matrix derived tissue engineering scaffold material | |
| CN110665055B (en) | Sericin/nano-hydroxyapatite tissue engineering bone graft and preparation method and application thereof | |
| Jang et al. | Effect of umbilical cord serum coated 3D PCL/alginate scaffold for mastoid obliteration | |
| Hu et al. | Construction of 3D-Bioprinted cartilage-mimicking substitute based on photo-crosslinkable Wharton's jelly bioinks for full-thickness articular cartilage defect repair | |
| CN102552985A (en) | Silk fibroin/calcium phosphate bone cement-based porous composite material and preparation method thereof | |
| CN106039400B (en) | Preparation method and application of three-dimensional bioscaffold with regular lamellar structure by ice crystal template method | |
| CN101690830B (en) | Preparation method of bionic cartilage extracellular matrix for tissue engineering | |
| CN110787324A (en) | Preparation method of drug controlled release polylactic acid-based bone repair scaffold material | |
| CN105816915A (en) | Mesenchymal stem cell tissue engineering scaffold and preparation method and application thereof | |
| Ghanbari et al. | A review of recent advances on osteogenic applications of Silk fibroin as a potential bio-scaffold in bone tissue engineering | |
| CN108553690B (en) | Strontium-doped porous silk fibroin microspheres and preparation method thereof | |
| JP6386824B2 (en) | Method for producing cross-linked gelatin sponge | |
| CN106620854A (en) | Elastin-like silk fiber porous composite material and application thereof | |
| Li et al. | Radially porous nonmulberry silk fibroin nanofiber scaffolds for bone repair | |
| CN108553689A (en) | A kind of fibroin porous microsphere and preparation method thereof with nanofiber micro-structure | |
| CN110639060A (en) | A 3D bioprinted silk fibroin-based tissue engineering scaffold and its preparation method and application | |
| Li et al. | 3D printed hydroxyapatite/silk fibroin/polycaprolactone artificial bone scaffold and bone tissue engineering materials constructed with double-transfected bone morphogenetic protein-2 and vascular endothelial growth factor mesenchymal stem cells to repair rabbit radial bone defects | |
| CN108498861A (en) | A kind of preparation method of hydroxyapatite-fibroin-titanium dioxide biomaterial |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |